The trajectory of Sildenafil presents a challenging picture for investors. While the initial release generated significant profits, the lapse of its exclusive rights opened the avenue to off-brand competitors, https://isocialfans.com/story7225223/viagra-and-the-pharmaceutical-industry-a-risky-bet